Pfizer Weekly: Selling Into Obesity‑Hype ResistancePfizer Inc.BATS:PFEConnectmyCurrencyPfizer (PFE) is pushing into weekly resistance after an obesity‑pipeline bounce, but the long‑term trend and post‑COVID overhang keep the broader structure heavy, so I’m treating this move as a place to sell rather than chase. My plan is to use this zone to enter/hold shorts with stops beyond the recent weekly highs, targeting a rotation back toward prior support if the hype around new GLP‑1 data fades again. If you’d like to learn more about how I trade setups like this, you can find more details about me and my work in my profile bio.